The global In Vitro Dissolution Testing market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.

In vitro dissolution testing is a laboratory procedure used to measure the rate and extent to which a drug substance is released from its dosage form (such as tablets, capsules, or suspensions) into a solution under standardized conditions. This testing is performed in a controlled environment that simulates the conditions within the gastrointestinal tract but does not involve living organisms (hence "in vitro," which means "in glass").

From a downstream perspective, Pharmaceutical accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).

In Vitro Dissolution Testing leading manufacturers including Raptim Research, SGS, The J. Molner Company, BioLInk LIfe Sciences, Joanneum Research, Stira Pharmaceuticals, CPL, MedPharm, Eurofins, Diteba, etc., dominate supply; the top five capture approximately % of global revenue, with Raptim Research leading 2024 sales at US$ million.

Regional Outlook:

North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).

Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).

Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global In Vitro Dissolution Testing market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.

Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.

Market Segmentation

Scope of In Vitro Dissolution Testing Market Report

Report Metric	Details
Report Name	In Vitro Dissolution Testing Market
Segment by Type	Capsules Tablets Others
Segment by Application	Pharmaceutical Drug Toxicology Research
Sales by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Raptim Research, SGS, The J. Molner Company, BioLInk LIfe Sciences, Joanneum Research, Stira Pharmaceuticals, CPL, MedPharm, Eurofins, Diteba, Nuvisan, QPS, CD Formulation, Tergus Pharma, Pion, Sun-Novo, Frontage, Porton, Standard Testing Group
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the In Vitro Dissolution Testing study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the In Vitro Dissolution Testing Market report?

Ans: The main players in the In Vitro Dissolution Testing Market are Raptim Research, SGS, The J. Molner Company, BioLInk LIfe Sciences, Joanneum Research, Stira Pharmaceuticals, CPL, MedPharm, Eurofins, Diteba, Nuvisan, QPS, CD Formulation, Tergus Pharma, Pion, Sun-Novo, Frontage, Porton, Standard Testing Group

What are the Application segmentation covered in the In Vitro Dissolution Testing Market report?

Ans: The Applications covered in the In Vitro Dissolution Testing Market report are Pharmaceutical, Drug Toxicology Research

What are the Type segmentation covered in the In Vitro Dissolution Testing Market report?

Ans: The Types covered in the In Vitro Dissolution Testing Market report are Capsules, Tablets, Others

1 Study Coverage

1.1 Introduction to In Vitro Dissolution Testing: Definition, Properties, and Key Attributes

1.2 Market Segmentation by Type

1.2.1 Global In Vitro Dissolution Testing Market Size by Type, 2020 VS 2024 VS 2031

1.2.2 Capsules

1.2.3 Tablets

1.2.4 Others

1.3 Market Segmentation by Application

1.3.1 Global In Vitro Dissolution Testing Market Size by Application, 2020 VS 2024 VS 2031

1.3.2 Pharmaceutical

1.3.3 Drug Toxicology Research

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global In Vitro Dissolution Testing Revenue Estimates and Forecasts 2020-2031

2.2 Global In Vitro Dissolution Testing Revenue by Region

2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031

2.2.2 Historical and Forecasted Revenue by Region (2020-2031)

2.2.3 Global Revenue Market Share by Region (2020-2031)

2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends

3 Competition by Players

3.1 Global In Vitro Dissolution Testing Player Revenue Rankings and Profitability

3.1.1 Global Revenue (Value) by Players (2020-2025)

3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)

3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)

3.1.4 Gross Margin by Top Player (2020 VS 2024)

3.2 Global In Vitro Dissolution Testing Companies Headquarters and Service Footprint

3.3 Main Product Type Market Size by Players

3.3.1 Capsules Market Size by Players

3.3.2 Tablets Market Size by Players

3.3.3 Others Market Size by Players

3.4 Global In Vitro Dissolution Testing Market Concentration and Dynamics

3.4.1 Global Market Concentration (CR5 and HHI)

3.4.2 Entrant/Exit Impact Analysis

3.4.3 Strategic Moves: M&A, Expansion, R&D Investment

4 Global Product Segmentation Analysis

4.1 Global In Vitro Dissolution Testing Revenue Trends by Type

4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)

4.1.2 Global Revenue Market Share by Type (2020-2031)

4.2 Key Product Attributes and Differentiation

4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk

4.3.1 High-Growth Niches and Adoption Drivers

4.3.2 Profitability Hotspots and Cost Drivers

4.3.3 Substitution Threats

5 Global Downstream Application Analysis

5.1 Global In Vitro Dissolution Testing Revenue by Application

5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)

5.1.2 Revenue Market Share by Application (2020-2031)

5.1.3 High-Growth Application Identification

5.1.4 Emerging Application Case Studies

5.2 Downstream Customer Analysis

5.2.1 Top Customers by Region

5.2.2 Top Customers by Application

6 North America

6.1 North America Market Size (2020-2031)

6.2 North America Key Players Revenue in 2024

6.3 North America In Vitro Dissolution Testing Market Size by Type (2020-2031)

6.4 North America In Vitro Dissolution Testing Market Size by Application (2020-2031)

6.5 North America Growth Accelerators and Market Barriers

6.6 North America In Vitro Dissolution Testing Market Size by Country

6.6.1 North America Revenue Trends by Country

6.6.2 US

6.6.3 Canada

6.6.4 Mexico

7 Europe

7.1 Europe Market Size (2020-2031)

7.2 Europe Key Players Revenue in 2024

7.3 Europe In Vitro Dissolution Testing Market Size by Type (2020-2031)

7.4 Europe In Vitro Dissolution Testing Market Size by Application (2020-2031)

7.5 Europe Growth Accelerators and Market Barriers

7.6 Europe In Vitro Dissolution Testing Market Size by Country

7.6.1 Europe Revenue Trends by Country

7.6.2 Germany

7.6.3 France

7.6.4 U.K.

7.6.5 Italy

7.6.6 Russia

8 Asia-Pacific

8.1 Asia-Pacific Market Size (2020-2031)

8.2 Asia-Pacific Key Players Revenue in 2024

8.3 Asia-Pacific In Vitro Dissolution Testing Market Size by Type (2020-2031)

8.4 Asia-Pacific In Vitro Dissolution Testing Market Size by Application (2020-2031)

8.5 Asia-Pacific Growth Accelerators and Market Barriers

8.6 Asia-Pacific In Vitro Dissolution Testing Market Size by Region

8.6.1 Asia-Pacific Revenue Trends by Region

8.7 China

8.8 Japan

8.9 South Korea

8.10 Australia

8.11 India

8.12 Southeast Asia

8.12.1 Indonesia

8.12.2 Vietnam

8.12.3 Malaysia

8.12.4 Philippines

8.12.5 Singapore

9 Central and South America

9.1 Central and South America Market Size (2020-2031)

9.2 Central and South America Key Players Revenue in 2024

9.3 Central and South America In Vitro Dissolution Testing Market Size by Type (2020-2031)

9.4 Central and South America In Vitro Dissolution Testing Market Size by Application (2020-2031)

9.5 Central and South America Investment Opportunities and Key Challenges

9.6 Central and South America In Vitro Dissolution Testing Market Size by Country

9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)

9.6.2 Brazil

9.6.3 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Market Size (2020-2031)

10.2 Middle East and Africa Key Players Revenue in 2024

10.3 Middle East and Africa In Vitro Dissolution Testing Market Size by Type (2020-2031)

10.4 Middle East and Africa In Vitro Dissolution Testing Market Size by Application (2020-2031)

10.5 Middle East and Africa Investment Opportunities and Key Challenges

10.6 Middle East and Africa In Vitro Dissolution Testing Market Size by Country

10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)

10.6.2 GCC Countries

10.6.3 Israel

10.6.4 Egypt

10.6.5 South Africa

11 Corporate Profile

11.1 Raptim Research

11.1.1 Raptim Research Corporation Information

11.1.2 Raptim Research Business Overview

11.1.3 Raptim Research In Vitro Dissolution Testing Product Features and Attributes

11.1.4 Raptim Research In Vitro Dissolution Testing Revenue and Gross Margin (2020-2025)

11.1.5 Raptim Research In Vitro Dissolution Testing Revenue by Product in 2024

11.1.6 Raptim Research In Vitro Dissolution Testing Revenue by Application in 2024

11.1.7 Raptim Research In Vitro Dissolution Testing Revenue by Geographic Area in 2024

11.1.8 Raptim Research In Vitro Dissolution Testing SWOT Analysis

11.1.9 Raptim Research Recent Developments

11.2 SGS

11.2.1 SGS Corporation Information

11.2.2 SGS Business Overview

11.2.3 SGS In Vitro Dissolution Testing Product Features and Attributes

11.2.4 SGS In Vitro Dissolution Testing Revenue and Gross Margin (2020-2025)

11.2.5 SGS In Vitro Dissolution Testing Revenue by Product in 2024

11.2.6 SGS In Vitro Dissolution Testing Revenue by Application in 2024

11.2.7 SGS In Vitro Dissolution Testing Revenue by Geographic Area in 2024

11.2.8 SGS In Vitro Dissolution Testing SWOT Analysis

11.2.9 SGS Recent Developments

11.3 The J. Molner Company

11.3.1 The J. Molner Company Corporation Information

11.3.2 The J. Molner Company Business Overview

11.3.3 The J. Molner Company In Vitro Dissolution Testing Product Features and Attributes

11.3.4 The J. Molner Company In Vitro Dissolution Testing Revenue and Gross Margin (2020-2025)

11.3.5 The J. Molner Company In Vitro Dissolution Testing Revenue by Product in 2024

11.3.6 The J. Molner Company In Vitro Dissolution Testing Revenue by Application in 2024

11.3.7 The J. Molner Company In Vitro Dissolution Testing Revenue by Geographic Area in 2024

11.3.8 The J. Molner Company In Vitro Dissolution Testing SWOT Analysis

11.3.9 The J. Molner Company Recent Developments

11.4 BioLInk LIfe Sciences

11.4.1 BioLInk LIfe Sciences Corporation Information

11.4.2 BioLInk LIfe Sciences Business Overview

11.4.3 BioLInk LIfe Sciences In Vitro Dissolution Testing Product Features and Attributes

11.4.4 BioLInk LIfe Sciences In Vitro Dissolution Testing Revenue and Gross Margin (2020-2025)

11.4.5 BioLInk LIfe Sciences In Vitro Dissolution Testing Revenue by Product in 2024

11.4.6 BioLInk LIfe Sciences In Vitro Dissolution Testing Revenue by Application in 2024

11.4.7 BioLInk LIfe Sciences In Vitro Dissolution Testing Revenue by Geographic Area in 2024

11.4.8 BioLInk LIfe Sciences In Vitro Dissolution Testing SWOT Analysis

11.4.9 BioLInk LIfe Sciences Recent Developments

11.5 Joanneum Research

11.5.1 Joanneum Research Corporation Information

11.5.2 Joanneum Research Business Overview

11.5.3 Joanneum Research In Vitro Dissolution Testing Product Features and Attributes

11.5.4 Joanneum Research In Vitro Dissolution Testing Revenue and Gross Margin (2020-2025)

11.5.5 Joanneum Research In Vitro Dissolution Testing Revenue by Product in 2024

11.5.6 Joanneum Research In Vitro Dissolution Testing Revenue by Application in 2024

11.5.7 Joanneum Research In Vitro Dissolution Testing Revenue by Geographic Area in 2024

11.5.8 Joanneum Research In Vitro Dissolution Testing SWOT Analysis

11.5.9 Joanneum Research Recent Developments

11.6 Stira Pharmaceuticals

11.6.1 Stira Pharmaceuticals Corporation Information

11.6.2 Stira Pharmaceuticals Business Overview

11.6.3 Stira Pharmaceuticals In Vitro Dissolution Testing Product Features and Attributes

11.6.4 Stira Pharmaceuticals In Vitro Dissolution Testing Revenue and Gross Margin (2020-2025)

11.6.5 Stira Pharmaceuticals Recent Developments

11.7 CPL

11.7.1 CPL Corporation Information

11.7.2 CPL Business Overview

11.7.3 CPL In Vitro Dissolution Testing Product Features and Attributes

11.7.4 CPL In Vitro Dissolution Testing Revenue and Gross Margin (2020-2025)

11.7.5 CPL Recent Developments

11.8 MedPharm

11.8.1 MedPharm Corporation Information

11.8.2 MedPharm Business Overview

11.8.3 MedPharm In Vitro Dissolution Testing Product Features and Attributes

11.8.4 MedPharm In Vitro Dissolution Testing Revenue and Gross Margin (2020-2025)

11.8.5 MedPharm Recent Developments

11.9 Eurofins

11.9.1 Eurofins Corporation Information

11.9.2 Eurofins Business Overview

11.9.3 Eurofins In Vitro Dissolution Testing Product Features and Attributes

11.9.4 Eurofins In Vitro Dissolution Testing Revenue and Gross Margin (2020-2025)

11.9.5 Eurofins Recent Developments

11.10 Diteba

11.10.1 Diteba Corporation Information

11.10.2 Diteba Business Overview

11.10.3 Diteba In Vitro Dissolution Testing Product Features and Attributes

11.10.4 Diteba In Vitro Dissolution Testing Revenue and Gross Margin (2020-2025)

11.10.5 Company Ten Recent Developments

11.11 Nuvisan

11.11.1 Nuvisan Corporation Information

11.11.2 Nuvisan Business Overview

11.11.3 Nuvisan In Vitro Dissolution Testing Product Features and Attributes

11.11.4 Nuvisan In Vitro Dissolution Testing Revenue and Gross Margin (2020-2025)

11.11.5 Nuvisan Recent Developments

11.12 QPS

11.12.1 QPS Corporation Information

11.12.2 QPS Business Overview

11.12.3 QPS In Vitro Dissolution Testing Product Features and Attributes

11.12.4 QPS In Vitro Dissolution Testing Revenue and Gross Margin (2020-2025)

11.12.5 QPS Recent Developments

11.13 CD Formulation

11.13.1 CD Formulation Corporation Information

11.13.2 CD Formulation Business Overview

11.13.3 CD Formulation In Vitro Dissolution Testing Product Features and Attributes

11.13.4 CD Formulation In Vitro Dissolution Testing Revenue and Gross Margin (2020-2025)

11.13.5 CD Formulation Recent Developments

11.14 Tergus Pharma

11.14.1 Tergus Pharma Corporation Information

11.14.2 Tergus Pharma Business Overview

11.14.3 Tergus Pharma In Vitro Dissolution Testing Product Features and Attributes

11.14.4 Tergus Pharma In Vitro Dissolution Testing Revenue and Gross Margin (2020-2025)

11.14.5 Tergus Pharma Recent Developments

11.15 Pion

11.15.1 Pion Corporation Information

11.15.2 Pion Business Overview

11.15.3 Pion In Vitro Dissolution Testing Product Features and Attributes

11.15.4 Pion In Vitro Dissolution Testing Revenue and Gross Margin (2020-2025)

11.15.5 Pion Recent Developments

11.16 Sun-Novo

11.16.1 Sun-Novo Corporation Information

11.16.2 Sun-Novo Business Overview

11.16.3 Sun-Novo In Vitro Dissolution Testing Product Features and Attributes

11.16.4 Sun-Novo In Vitro Dissolution Testing Revenue and Gross Margin (2020-2025)

11.16.5 Sun-Novo Recent Developments

11.17 Frontage

11.17.1 Frontage Corporation Information

11.17.2 Frontage Business Overview

11.17.3 Frontage In Vitro Dissolution Testing Product Features and Attributes

11.17.4 Frontage In Vitro Dissolution Testing Revenue and Gross Margin (2020-2025)

11.17.5 Frontage Recent Developments

11.18 Porton

11.18.1 Porton Corporation Information

11.18.2 Porton Business Overview

11.18.3 Porton In Vitro Dissolution Testing Product Features and Attributes

11.18.4 Porton In Vitro Dissolution Testing Revenue and Gross Margin (2020-2025)

11.18.5 Porton Recent Developments

11.19 Standard Testing Group

11.19.1 Standard Testing Group Corporation Information

11.19.2 Standard Testing Group Business Overview

11.19.3 Standard Testing Group In Vitro Dissolution Testing Product Features and Attributes

11.19.4 Standard Testing Group In Vitro Dissolution Testing Revenue and Gross Margin (2020-2025)

11.19.5 Standard Testing Group Recent Developments

12 In Vitro Dissolution TestingIndustry Chain Analysis

12.1 In Vitro Dissolution Testing Industry Chain

12.2 Upstream Analysis

12.2.1 Upstream Key Suppliers

12.3 Middlestream Analysis

12.4 Downstream Sales Model and Distribution Networks

12.4.1 Sales Channels

12.4.2 Distributors

13 In Vitro Dissolution Testing Market Dynamics

13.1 Industry Trends and Evolution

13.2 Market Growth Drivers and Emerging Opportunities

13.3 Market Challenges, Risks, and Restraints

14 Key Findings in the Global In Vitro Dissolution Testing Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

15.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Author Details

FEATURED COMPANIES

Raptim Research

SGS Ltd

The J. Molner Company

BioLink Life Sciences

JOANNEUM RESEARCH

Stira Pharmaceuticals

Standard Testing Group

List of Tables

Table 1. Global In Vitro Dissolution Testing Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Table 2. Global In Vitro Dissolution Testing Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Table 3. Global In Vitro Dissolution Testing Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 4. Global In Vitro Dissolution Testing Revenue by Region (2020-2025) & (US$ Million)

Table 5. Global In Vitro Dissolution Testing Revenue by Region (2026-2031) & (US$ Million)

Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 7. Global In Vitro Dissolution Testing Revenue by Players (2020-2025) & (US$ Million)

Table 8. Global In Vitro Dissolution Testing Revenue Market Share by Players (2020-2025)

Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)

Table 10. Global In Vitro Dissolution Testing by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In Vitro Dissolution Testing as of 2024)

Table 11. Global In Vitro Dissolution Testing Average Gross Margin (%) by Player (2020 VS 2024)

Table 12. Global In Vitro Dissolution Testing Companies Headquarters

Table 13. Global In Vitro Dissolution Testing Market Concentration Ratio (CR5 and HHI)

Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis

Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment

Table 16. Global In Vitro Dissolution Testing Revenue by Type (2020-2025) & (US$ Million)

Table 17. Global In Vitro Dissolution Testing Revenue by Type (2026-2031) & (US$ Million)

Table 18. Key Product Attributes and Differentiation

Table 19. Global In Vitro Dissolution Testing Revenue by Application (2020-2025) & (US$ Million)

Table 20. Global In Vitro Dissolution Testing Revenue by Application (2026-2031) & (US$ Million)

Table 21. In Vitro Dissolution Testing High-Growth Sectors Demand CAGR (2024-2031)

Table 22. Top Customers by Region

Table 23. Top Customers by Application

Table 24. North America In Vitro Dissolution Testing Growth Accelerators and Market Barriers

Table 25. North America In Vitro Dissolution Testing Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 26. Europe In Vitro Dissolution Testing Growth Accelerators and Market Barriers

Table 27. Europe In Vitro Dissolution Testing Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 28. Asia-Pacific In Vitro Dissolution Testing Growth Accelerators and Market Barriers

Table 29. Asia-Pacific In Vitro Dissolution Testing Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 30. Central and South America In Vitro Dissolution Testing Investment Opportunities and Key Challenges

Table 31. Central and South America In Vitro Dissolution Testing Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 32. Middle East and Africa In Vitro Dissolution Testing Investment Opportunities and Key Challenges

Table 33. Middle East and Africa In Vitro Dissolution Testing Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 34. Raptim Research Corporation Information

Table 35. Raptim Research Description and Major Businesses

Table 36. Raptim Research Product Features and Attributes

Table 37. Raptim Research Revenue (US$ Million) and Gross Margin (2020-2025)

Table 38. Raptim Research Revenue Proportion by Product in 2024

Table 39. Raptim Research Revenue Proportion by Application in 2024

Table 40. Raptim Research Revenue Proportion by Geographic Area in 2024

Table 41. Raptim Research In Vitro Dissolution Testing SWOT Analysis

Table 42. Raptim Research Recent Developments

Table 43. SGS Corporation Information

Table 44. SGS Description and Major Businesses

Table 45. SGS Product Features and Attributes

Table 46. SGS Revenue (US$ Million) and Gross Margin (2020-2025)

Table 47. SGS Revenue Proportion by Product in 2024

Table 48. SGS Revenue Proportion by Application in 2024

Table 49. SGS Revenue Proportion by Geographic Area in 2024

Table 50. SGS In Vitro Dissolution Testing SWOT Analysis

Table 51. SGS Recent Developments

Table 52. The J. Molner Company Corporation Information

Table 53. The J. Molner Company Description and Major Businesses

Table 54. The J. Molner Company Product Features and Attributes

Table 55. The J. Molner Company Revenue (US$ Million) and Gross Margin (2020-2025)

Table 56. The J. Molner Company Revenue Proportion by Product in 2024

Table 57. The J. Molner Company Revenue Proportion by Application in 2024

Table 58. The J. Molner Company Revenue Proportion by Geographic Area in 2024

Table 59. The J. Molner Company In Vitro Dissolution Testing SWOT Analysis

Table 60. The J. Molner Company Recent Developments

Table 61. BioLInk LIfe Sciences Corporation Information

Table 62. BioLInk LIfe Sciences Description and Major Businesses

Table 63. BioLInk LIfe Sciences Product Features and Attributes

Table 64. BioLInk LIfe Sciences Revenue (US$ Million) and Gross Margin (2020-2025)

Table 65. BioLInk LIfe Sciences Revenue Proportion by Product in 2024

Table 66. BioLInk LIfe Sciences Revenue Proportion by Application in 2024

Table 67. BioLInk LIfe Sciences Revenue Proportion by Geographic Area in 2024

Table 68. BioLInk LIfe Sciences In Vitro Dissolution Testing SWOT Analysis

Table 69. BioLInk LIfe Sciences Recent Developments

Table 70. Joanneum Research Corporation Information

Table 71. Joanneum Research Description and Major Businesses

Table 72. Joanneum Research Product Features and Attributes

Table 73. Joanneum Research Revenue (US$ Million) and Gross Margin (2020-2025)

Table 74. Joanneum Research Revenue Proportion by Product in 2024

Table 75. Joanneum Research Revenue Proportion by Application in 2024

Table 76. Joanneum Research Revenue Proportion by Geographic Area in 2024

Table 77. Joanneum Research In Vitro Dissolution Testing SWOT Analysis

Table 78. Joanneum Research Recent Developments

Table 79. Stira Pharmaceuticals Corporation Information

Table 80. Stira Pharmaceuticals Description and Major Businesses

Table 81. Stira Pharmaceuticals Product Features and Attributes

Table 82. Stira Pharmaceuticals Revenue (US$ Million) and Gross Margin (2020-2025)

Table 83. Stira Pharmaceuticals Recent Developments

Table 84. CPL Corporation Information

Table 85. CPL Description and Major Businesses

Table 86. CPL Product Features and Attributes

Table 87. CPL Revenue (US$ Million) and Gross Margin (2020-2025)

Table 88. CPL Recent Developments

Table 89. MedPharm Corporation Information

Table 90. MedPharm Description and Major Businesses

Table 91. MedPharm Product Features and Attributes

Table 92. MedPharm Revenue (US$ Million) and Gross Margin (2020-2025)

Table 93. MedPharm Recent Developments

Table 94. Eurofins Corporation Information

Table 95. Eurofins Description and Major Businesses

Table 96. Eurofins Product Features and Attributes

Table 97. Eurofins Revenue (US$ Million) and Gross Margin (2020-2025)

Table 98. Eurofins Recent Developments

Table 99. Diteba Corporation Information

Table 100. Diteba Description and Major Businesses

Table 101. Diteba Product Features and Attributes

Table 102. Diteba Revenue (US$ Million) and Gross Margin (2020-2025)

Table 103. Diteba Recent Developments

Table 104. Nuvisan Corporation Information

Table 105. Nuvisan Description and Major Businesses

Table 106. Nuvisan Product Features and Attributes

Table 107. Nuvisan Revenue (US$ Million) and Gross Margin (2020-2025)

Table 108. Nuvisan Recent Developments

Table 109. QPS Corporation Information

Table 110. QPS Description and Major Businesses

Table 111. QPS Product Features and Attributes

Table 112. QPS Revenue (US$ Million) and Gross Margin (2020-2025)

Table 113. QPS Recent Developments

Table 114. CD Formulation Corporation Information

Table 115. CD Formulation Description and Major Businesses

Table 116. CD Formulation Product Features and Attributes

Table 117. CD Formulation Revenue (US$ Million) and Gross Margin (2020-2025)

Table 118. CD Formulation Recent Developments

Table 119. Tergus Pharma Corporation Information

Table 120. Tergus Pharma Description and Major Businesses

Table 121. Tergus Pharma Product Features and Attributes

Table 122. Tergus Pharma Revenue (US$ Million) and Gross Margin (2020-2025)

Table 123. Tergus Pharma Recent Developments

Table 124. Pion Corporation Information

Table 125. Pion Description and Major Businesses

Table 126. Pion Product Features and Attributes

Table 127. Pion Revenue (US$ Million) and Gross Margin (2020-2025)

Table 128. Pion Recent Developments

Table 129. Sun-Novo Corporation Information

Table 130. Sun-Novo Description and Major Businesses

Table 131. Sun-Novo Product Features and Attributes

Table 132. Sun-Novo Revenue (US$ Million) and Gross Margin (2020-2025)

Table 133. Sun-Novo Recent Developments

Table 134. Frontage Corporation Information

Table 135. Frontage Description and Major Businesses

Table 136. Frontage Product Features and Attributes

Table 137. Frontage Revenue (US$ Million) and Gross Margin (2020-2025)

Table 138. Frontage Recent Developments

Table 139. Porton Corporation Information

Table 140. Porton Description and Major Businesses

Table 141. Porton Product Features and Attributes

Table 142. Porton Revenue (US$ Million) and Gross Margin (2020-2025)

Table 143. Porton Recent Developments

Table 144. Standard Testing Group Corporation Information

Table 145. Standard Testing Group Description and Major Businesses

Table 146. Standard Testing Group Product Features and Attributes

Table 147. Standard Testing Group Revenue (US$ Million) and Gross Margin (2020-2025)

Table 148. Standard Testing Group Recent Developments

Table 149. Raw Materials Key Suppliers

Table 150. Distributors List

Table 151. Market Trends and Market Evolution

Table 152. Market Drivers and Opportunities

Table 153. Market Challenges, Risks, and Restraints

Table 154. Research Programs/Design for This Report

Table 155. Key Data Information from Secondary Sources

Table 156. Key Data Information from Primary Sources

List of Figures

Figure 1. In Vitro Dissolution Testing Product Picture

Figure 2. Global In Vitro Dissolution Testing Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Capsules Product Picture

Figure 4. Tablets Product Picture

Figure 5. Others Product Picture

Figure 6. Global In Vitro Dissolution Testing Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Figure 7. Pharmaceutical

Figure 8. Drug Toxicology Research

Figure 9. In Vitro Dissolution Testing Report Years Considered

Figure 10. Global In Vitro Dissolution Testing Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 11. Global In Vitro Dissolution Testing Revenue (2020-2031) & (US$ Million)

Figure 12. Global In Vitro Dissolution Testing Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 13. Global In Vitro Dissolution Testing Revenue Market Share by Region (2020-2031)

Figure 14. Global In Vitro Dissolution Testing Revenue Market Share Ranking (2024)

Figure 15. Tier Distribution by Revenue Contribution (2020 VS 2024)

Figure 16. Capsules Revenue Market Share by Player in 2024

Figure 17. Tablets Revenue Market Share by Player in 2024

Figure 18. Others Revenue Market Share by Player in 2024

Figure 19. Global In Vitro Dissolution Testing Revenue Market Share by Type (2020-2031)

Figure 20. Global In Vitro Dissolution Testing Revenue Market Share by Application (2020-2031)

Figure 21. North America In Vitro Dissolution Testing Revenue YoY (2020-2031) & (US$ Million)

Figure 22. North America Top 5 Players In Vitro Dissolution Testing Revenue (US$ Million) in 2024

Figure 23. North America In Vitro Dissolution Testing Revenue (US$ Million) by Type (2020 - 2031)

Figure 24. North America In Vitro Dissolution Testing Revenue (US$ Million) by Application (2020-2031)

Figure 25. US In Vitro Dissolution Testing Revenue (2020-2031) & (US$ Million)

Figure 26. Canada In Vitro Dissolution Testing Revenue (2020-2031) & (US$ Million)

Figure 27. Mexico In Vitro Dissolution Testing Revenue (2020-2031) & (US$ Million)

Figure 28. Europe In Vitro Dissolution Testing Revenue YoY (2020-2031) & (US$ Million)

Figure 29. Europe Top 5 Players In Vitro Dissolution Testing Revenue (US$ Million) in 2024

Figure 30. Europe In Vitro Dissolution Testing Revenue (US$ Million) by Type (2020-2031)

Figure 31. Europe In Vitro Dissolution Testing Revenue (US$ Million) by Application (2020-2031)

Figure 32. Germany In Vitro Dissolution Testing Revenue (2020-2031) & (US$ Million)

Figure 33. France In Vitro Dissolution Testing Revenue (2020-2031) & (US$ Million)

Figure 34. U.K. In Vitro Dissolution Testing Revenue (2020-2031) & (US$ Million)

Figure 35. Italy In Vitro Dissolution Testing Revenue (2020-2031) & (US$ Million)

Figure 36. Russia In Vitro Dissolution Testing Revenue (2020-2031) & (US$ Million)

Figure 37. Asia-Pacific In Vitro Dissolution Testing Revenue YoY (2020-2031) & (US$ Million)

Figure 38. Asia-Pacific Top 8 Players In Vitro Dissolution Testing Revenue (US$ Million) in 2024

Figure 39. Asia-Pacific In Vitro Dissolution Testing Revenue (US$ Million) by Type (2020-2031)

Figure 40. Asia-Pacific In Vitro Dissolution Testing Revenue (US$ Million) by Application (2020-2031)

Figure 41. Indonesia In Vitro Dissolution Testing Revenue (2020-2031) & (US$ Million)

Figure 42. Japan In Vitro Dissolution Testing Revenue (2020-2031) & (US$ Million)

Figure 43. South Korea In Vitro Dissolution Testing Revenue (2020-2031) & (US$ Million)

Figure 44. Australia In Vitro Dissolution Testing Revenue (2020-2031) & (US$ Million)

Figure 45. India In Vitro Dissolution Testing Revenue (2020-2031) & (US$ Million)

Figure 46. Indonesia In Vitro Dissolution Testing Revenue (2020-2031) & (US$ Million)

Figure 47. Vietnam In Vitro Dissolution Testing Revenue (2020-2031) & (US$ Million)

Figure 48. Malaysia In Vitro Dissolution Testing Revenue (2020-2031) & (US$ Million)

Figure 49. Philippines In Vitro Dissolution Testing Revenue (2020-2031) & (US$ Million)

Figure 50. Singapore In Vitro Dissolution Testing Revenue (2020-2031) & (US$ Million)

Figure 51. Central and South America In Vitro Dissolution Testing Revenue YoY (2020-2031) & (US$ Million)

Figure 52. Central and South America Top 5 Players In Vitro Dissolution Testing Revenue (US$ Million) in 2024

Figure 53. Central and South America In Vitro Dissolution Testing Revenue (US$ Million) by Type (2020-2031)

Figure 54. Central and South America In Vitro Dissolution Testing Revenue (US$ Million) by Application (2020-2031)

Figure 55. Brazil In Vitro Dissolution Testing Revenue (2020-2025) & (US$ Million)

Figure 56. Argentina In Vitro Dissolution Testing Revenue (2020-2025) & (US$ Million)

Figure 57. Middle East and Africa In Vitro Dissolution Testing Revenue YoY (2020-2031) & (US$ Million)

Figure 58. Middle East and Africa Top 5 Players In Vitro Dissolution Testing Revenue (US$ Million) in 2024

Figure 59. South America In Vitro Dissolution Testing Revenue (US$ Million) by Type (2020-2031)

Figure 60. Middle East and Africa In Vitro Dissolution Testing Revenue (US$ Million) by Application (2020-2031)

Figure 61. GCC Countries In Vitro Dissolution Testing Revenue (2020-2025) & (US$ Million)

Figure 62. Israel In Vitro Dissolution Testing Revenue (2020-2025) & (US$ Million)

Figure 63. Egypt In Vitro Dissolution Testing Revenue (2020-2025) & (US$ Million)

Figure 64. South Africa In Vitro Dissolution Testing Revenue (2020-2025) & (US$ Million)

Figure 65. In Vitro Dissolution Testing Industry Chain Mapping

Figure 66. Channels of Distribution (Direct Vs Distribution)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Single-Use Bioprocessing Film Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-15C20068

Thu Oct 16 00:00:00 UTC 2025

Add to Cart

Global Site Management Organization (SMO) Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-19O20066

Wed Oct 15 00:00:00 UTC 2025

Add to Cart

Global Virtual ICU Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages

Type: Report

Code: QYRE-Auto-13D20078

Tue Oct 14 00:00:00 UTC 2025

Add to Cart

Global Alpha Particle Targeted Therapy Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages

Type: Report

Code: QYRE-Auto-1S17890

Tue Oct 14 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions